Fulminant Giant Cell Myocarditis Requiring Bridge With Mechanical Circulatory Support to Heart Transplantation

Yevgeniy Brailovsky; Amirali Masoumi; Rachel Bijou; Estefania Oliveros; Gabriel Sayer; Koji Takeda; Nir Uriel

doi:10.1016/j.jaccas.2021.11.013

Fulminant Giant Cell Myocarditis Requiring Bridge With Mechanical Circulatory Support to Heart Transplantation

JACC Case Rep. 2022 Mar 2;4(5):265-270. doi: 10.1016/j.jaccas.2021.11.013.

Authors

Yevgeniy Brailovsky¹, Amirali Masoumi², Rachel Bijou², Estefania Oliveros³, Gabriel Sayer², Koji Takeda⁴, Nir Uriel²

Affiliations

¹ Division of Cardiology, Jefferson Heart Institute, Sidney Kimmel School of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
² Division of Cardiology, Columbia University Irving Medical Center, New York, New York, USA.
³ Division of Cardiology, Temple University Hospital, Philadelphia, Pennsylvania, USA.
⁴ Division of Cardiovascular Surgery, Columbia University Irving Medical Center, New York, New York, USA.

Abstract

Giant cell myocarditis is a rare cause of cardiogenic shock requiring a high index of suspicion, rapid immunosuppressive therapy, and mechanical circulatory support. We present the case of a patient with giant cell myocarditis who underwent a successful bridge with four different types of mechanical circulatory support devices to heart transplantation. (Level of Difficulty: Advanced.).

Keywords: ECMO, extracorporeal membrane oxygenation; GCM, giant cell myocarditis; LVAD, left ventricular assist device; LVEF, left ventricular ejection fraction; OHT, orthotopic heart transplantation; PA, pulmonary artery; RA, right atrium; RV, right ventricle; acute heart failure; cardiac transplant; cardiomyopathy.

Publication types

Case Reports